| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MacRogenics Inc (MGNX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. MGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 152.2K | $697.2K | - | |
| Dir | 111.0K | $508.4K | - | |
| Dir | 0 | - | - | |
| CEO | 0 | - | - | |
| VP | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2021 | Spitznagel Thomas80 | Sr VP, Bpd &Manufacturing | Sale+OE | 5,000 | $30.91 | $154,550.00 | -100% | -25.2% | -73.6% | |
| Mar 22, 2021 | Karrels James82 | SVP, CFO And Secretary | Sell | 15,000 | $33.00 | $495,000.00 | -9.5% | -32.3% | -72.0% | |
| Mar 22, 2021 | Bonvini Ezio72 | Sr VP, Research &CSO | Sell | 3,917 | $32.00 | $125,344.00 | -4.7% | -32.3% | -72.0% | |
| Mar 8, 2021 | Peters Jeffrey Stuart74 | General Counsel | Sale+OE | 21,749 | $26.50 | $576,348.50 | -100% | - | - | |
| Dec 29, 2020 | Risser Eric Blasius | Sr VP &Chief Business Officer | Sale+OE | 500 | $24.10 | $12,050.00 | -1.1% | - | - | |
| Nov 30, 2020 | Risser Eric Blasius | Sr VP &Chief Business Officer | Sale+OE | 500 | $23.35 | $11,675.00 | -1.1% | - | - | |
| Oct 28, 2020 | Risser Eric Blasius | Sr VP &Chief Business Officer | Sale+OE | 1,500 | $20.69 | $31,035.00 | -3.3% | - | - | |
| Sep 28, 2020 | Risser Eric Blasius | Sr VP &Chief Business Officer | Sale+OE | 500 | $25.33 | $12,665.00 | -1.1% | - | - | |
| Sep 18, 2020 | Bonvini Ezio72 | Sr VP, Research &CSO | Sell | 62,851 | $30.50 | $1,916,866.56 | -25.3% | - | - | |
| Sep 9, 2020 | Galbraith Kenneth | Director | Sale+OE | 20,773 | $27.11 | $563,156.03 | -100% | - | - |